非正规的嗅觉通路激活诱导子宫癌细胞的细胞融合
Keigo Araki1, Takeru Torii2, Kohei Takeuchi2
1Department of Morphological Biology, School of Dentistry, Ohu University, Koriyama, Fukushima 963-8611, Japan.
概括
在晚期癌症中,多核化驱动药物耐药性. 研究人员确定了一种突变的嗅觉受体 (OR1N2),该受体促进细胞融合和多核化,这表明林抑制剂是改善癌症治疗结果的潜在疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 多核化是晚期癌症的特征,有助于恶性瘤和抗癌药物耐药性.
- 驱动癌症多核化的精确分子机制在很大程度上是未知的.
- 向多核化是一种潜在的策略,可以提高癌症治疗的疗效.
研究的目的:
- 阐明癌症中细胞融合介导的多核化背后的分子机制.
- 确定用于抑制多核化和克服晚期宫癌药物耐药性的新疗法标.
主要方法:
- 通过遗传突变诱导子宫癌细胞的细胞融合和多核化.
- 研究了嗅觉受体OR1N2及其突变在观察到的多核中所起的作用.
- 分析了涉及蛋白激酶A (PKA) 和蛋白酶的下游信号通路.
- 评估了林抑制剂在抑制多核化和增强抗癌药物效果方面的疗效.
主要成果:
- 在实验诱导和临床观察的多核子宫癌细胞中发现了嗅觉受体OR1N2的异构突变.
- 在OR1N2突变激活蛋白激酶A (PKA),启动一个非正规的嗅觉路径.
- 激活的PKA导致了酸化和激活furin蛋白酶,该蛋白质分裂了融合蛋白syncytin-1.
- 抑制furin蛋白酶显著抑制了多核化,并增加了癌细胞对抗癌药物的敏感性.
结论:
- 突变的OR1N2-PKA-furin-syncytin-1轴是导致宫癌多核化的关键途径.
- 林抑制剂代表了一种有前途的治疗策略,用于打击多核化,并增强现有的抗癌疗法对晚期宫癌的有效性.
相关概念视频
The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K


